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Summary 
Within 1 wk ofliquid culture in granulocyte/macrophage colony-stimulating factor (GM-CSF), 
normal B10 BR (H-2k I-E +) mouse liver nonparenchymal cells (NPC) formed loosely adherent 
myeloid cell clusters that have been shown to contain dendritic cell (DC) progenitors in similar 
studies of mouse blood or bone marrow. Mononuclear cell progeny released from these clusters 
at and beyond 4 d exhibited distinct dendritic morphology and were actively phagocytic. After 
6-10 d of culture, these cells strongly expressed CD45, CDllb, heat stable antigen, and CD44. 
However, the intensity of expression of the DC-restricted markers NLDC 145, 33D1, and N418, 
and the macrophage marker F4/80, intercellular adhesion molecule 1, and Fc'}'RII was low to 
moderate, whereas the cells were negative for CD3, CD4SRA, and NK1.1. Splenocytes prepared 
in the same way also had a similar range and intensity of expression of these immunophenotypic 
markers. Unlike the splenic DC, however, most of the GM-CSF-propagated putative liver DC 
harvested at 6-10 d expressed only a low level of major histocompatibility complex (MHC) class 
II (I-Ek), and they failed to induce primary allogeneic responses in naive T cells, even when 
propagated additionally in GM-CSF and tumor necrosis factor ex and/or interferon '}'-supplemented 
medium. However, when 7-d cultured GM-CSF-stirnulated liver cells were maintained additionally 
for three or more days on type-1 collagen-coated plates in the continued presence of GM-CSF, 
they exhibited characteristics of mature DC: MHC class II expression was markedly upregulated, 
mixed leukocyte reaction stimulatory activity was increased, and phagocytic function was decreased. 
Similar observations were made when Ia + cells were depleted from the GM-CSF-propagated 
cells before exposure to collagen. Further evidence that the GM-CSF-stimulated class IIdim or 
class II-depleted hepatic NPC were immature DC was obtained by injecting them into allogeneic 
B10 (H-2b I-E -) recipients. They "homed" to T cell-dependent areas oflymph nodes and spleen 
where they strongly expressed donor MHC class II antigen 1-5 d later. These observations provide 
insight into the regulation of DC maturation, and are congruent with the possibility that the 
migration of immature DC from normal liver and perhaps other organ allografts may help explain 
their inherent tolerogenicity. 
T he ubiquitous migration of leukocytes of bone marrow 
origin from transplanted organs into recipient tissues has 
been proposed as the first step toward organ allograft "accep-
tance" and the induction of variable degrees of donor-specific 
nonreactivity, which mayor may not require maintenance 
immunosuppression (1, 2). In this paradigm, the compara-
tive tolerogenicity and ease of acceptance of different organs 
is thought to hinge on their quantitative and qualitative en-
dowment with these passenger leukocytes, of which the bone 
marrow-derived dendritic cell (DC)l lineage, defined by 
Steinman and co-workers (3-5), has been postulated to be 
the most important (1, 2, 6). The liver, with its compara-
tively heavy content of DC and other leukocyte lineages, is 
1 Abbreviations used in this paper: DC, dendritic cell; NPC, nonparenchymal 
cell; RT, room temperature. 
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the most tolerogenic whole organ (7-9) and across most mouse 
strain combinations, can be transplanted successfully without 
host immunosuppression (10). Although liver interstitial DC, 
which are localized in the portal triads, have been character-
ized by immunohistochemical studies in both rodents (11, 
12) and humans (13), there are few published data concerning 
the in vitro properties ofliver-derived DC (14) and no reports 
of attempts to propagate DC lineage cells from normal liver. 
Consequently, we undertook a study of mouse liver DC, be-
ginning with the technique of lnaba et a1. who used GM-
CSF to propagate DC progeny from precursors present in 
mouse blood (15) or bone marrow (16). 
We report here on the immunophenotype and in vitro al-
lostimulatory activity of DC progenitors propagated selec-
tively from GM-CSF-stimulated Bl0.BR mouse liver non-
parenchymal cells (NPC). These cells were compared directly 
with similarly isolated and propagated spleen-derived DC. 
The results suggest a possible linkage between hepatic toleroge-
nicity and the presence, within the liver, of DC progenitors 
(MHC class IIdim) that proliferate rapidly and that resist con-
ventional attempts to induce maturation in vitro using GM-
CSF alone or in combination with either TNF-a or IFN-,,),. 
These same cells or la-depleted GM-CSF-propagated cells, 
however, could be induced to differentiate after prolonged 
exposure to GM-CSF in the presence of type-l collagen, an 
extracellular matrix protein spatially associated with DC 
within the normal liver (17). After subcutaneous injection 
into the footpad or intravenous injection into nonimmunosup-
pressed normal allogeneic recipients, the immature (MHC 
class II depleted or class IIdim) liver-derived cells also ex-
hibited the capacity, as previously described for DC (18-20), 
to home to T -dependent areas of secondary lymphoid tissue, 
where they upregulated their MHC class II expression. 
Materials and Methods 
Animals. Adult 8-1Z-wk-old male B10.BR (H_Zk, I-W) and 
C57BLi10SnJ (B10, H-2b, I-E-) mice were purchased from The 
Jackson Laboratory (Bar Harbor, ME). They were maintained in 
the specific pathogen-free facility of the University of Pittsburgh 
Medical Center. 
Isolation of NPC from Liver (See Fig. 1). BI0.BR mice were 
anaesthetized with metofen, swabbed with 70% ethanol, and an 
abdominal mid-line incision performed. The liver was perfused for 
3 min in situ via the inferior vena cava, using 30 ml HBSS (GIBCO 
BRL, Gaithersburg, MD) and a 22-G intravenous catheter (Critikon 
Inc., Tampa, FL). 2 ml collagenase solution (Sigma Chemical Co., 
St. Louis, MO; type IV, 1 mg/ml in HBSS) was then injected via 
the portal vein. The liver was excised immediately, diced into small 
pieces, and digested in collagenase solution (20 mllliver) for 30 
min at 37°C, with constant stirring. The digested tissue was then 
filtered through a O.1-mm sterile nylon mesh. Cells from two to 
four livers were pooled. 
The cell suspension was centrifuged and washed twice in RPMI-
1640 (GIBCO BRL) supplemented with Z mM/ml glutamine, 0.1 
mM/ml nonessential amino acids, 1 mM/ml sodium pyruvate, 20 
J.tM 2-ME and antibiotics (100 U/ml penicillin; 100 mg/ml strep-
tomycin; complete medium) at 400 g for 5 min. The cells were 
resuspended in 7 ml sterile, self-generating Percoll solution (Sigma 
Chemical Co.; 1.130 relative density) and centrifuged at 4°C for 
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Figure 1. Flow plan for isolation of liver NPC. 
10 min at 39,000 g using a SS34 rotor in a superspeed centrifuge 
(Sorvall RC-5B; DuPont Instruments, Chadds Ford, PA). The top 
layer of cells, containing intact hepatocytes and hepatocyte frag-
ments, was removed and discarded. The cell suspension between 
the upper and lower (erythrocyte) layer was then harvested and 
washed twice (5 min each in RPMI-1640). These cells constituted 
the liver NPC population. Control spleen cell populations were 
also prepared using the same protocol. 
Culture of Liver or Spleen-derived Celis with GM-CSF. To test the 
capacity of liver- or spleen-derived cells to proliferate in response 
to GM-CSF, 2-5 x 105 liver NPC or spleen cells were placed in 
each well of a 24-well plate in 2 ml of RPMI-1640, supplemented 
with 10% FCS and 0.4 ng/ml mouse rGM-CSF (R&D Systems, 
Inc., Minneapolis, MN). The cultures were "fed" every other day 
by aspirating 50'70 of the supernatant after gentle swirling, and 
replenishing with an equivalent volume of fresh GM-CSF-sup-
plemented medium. An objective of these washes was to remove 
nonadherent granulocytes, without dislodging clusters of developing 
DC that attached loosely to firmly adherent macrophages. After 
day 4, granulocytes were no longer significant contaminants of the 
cultures that were maintained routinely for 7-10 d. In some ex-
periments, in addition to GM-CSF, 500 U/ml recombinant mouse 
TNF-a (Genzyme Corp., Cambridge, MA) and/or 1,000 Ulml 
recombinant human IFN-'Y (Collaborative Research, Bedford, MA) 
was also incorporated in the culture medium. Both nonadherent 
and adherent cells were characterized by Giemsa staining. 
Depletion of MHC Class II-positive (Ia +) Celis. Cells released 
from growing clusters in 7-d GM-CSF-stimulated cultures of liver-
derived cells were depleted of any la + cells by complement-
dependent lysis. The harvested cells were washed three times in 
HBSS for 5 min each and resuspended at Z x 106/ml in HBSS 
containing 12.5 J.tg/ml mouse anti-I-Ek mAb (PharMingen, San 
Diego, CA). After incubation at 4°C for 30 min, the cells were 
washed twice, resuspended in 1:8 low toxicity rabbit complement 
(Accurate Chemical & Scientific Corp., Westbury, NY), and in-
cubated for a further 30 min at 37°C before two final washes. The 
efficiency of la+ cell depletion was confirmed by both immuno-
cytochemical staining of cytospins and flow cytometry. 
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Culture of Putative Liver DC on Collagen-coated plates. Each well 
of a 24-well plate was coated with collagen type-l (50 ILg/ml in 
0.02 N acetic acid) purified from rat tail tendon (Collaborative Re-
search) for 15 min at 37°C. The collagen solution was then decanted 
and the wells were allowed to air-dry for 15 min at room tempera-
ture (RT) before being washed twice in RPMI-1640 containing 
10'70 fetal bovine serum (FBS). Cells released from growing clusters 
in 6- or 7-d GM-CSF-stimulated cultures which were free of ad-
herent cells and granulocytes, were transferred to the plates (7 x 
105 cells/well) and maintained for a further 3 d in the presence of 
GM-CSF (0.4 ng/ml). In some experiments, the cells were pretreated 
to deplete all MHC class II+ cells (see above). 
Flow Cytometric Analysis. Liver or spleen cells (5 x 1051tube) 
in HBSS with 1% wt/vol BSA and 0.1 % sodium azide (both from 
Sigma Chemical Co.) were stained either by direct or indirect im-
munofluorescence. Details of the mAbs used are shown in Table 
1. Appropriate FITC-conjugated anti-mouse, anti-rat, or anti-ham-
ster secondary Abs were used. Normal hamster serum or the ap-
propriate rat or mouse Ig isotypes were used as negative controls. 
After staining, cells were fixed in 1% paraformaldehyde in saline 
Table 1. Monoclonal Antibody Panel 
Antigen 
Leukocyte Common Ag 
CD45 
CD45RA;B220 
MHC 
Class II; I-Ek,J,p" 
DC-restricted 
Lymphoid DC 
Interdigitating cell 
Myeloid (primarily) 
Macrophage 
Lymphoid (primarily) 
Thy 1.2 
CD3-E 
CD4 
CD8a 
Heat stable antigen 
NK cells 
NK 1.1 
LGL-l 
Receptors/ adhesins 
CD32, Fc')' RII 
CDllb, MAC-la unit; C3biR 
CDllc, p150/90 
CD44, Pgp-l 
CD54, ICAM-l 
CD25, p55; IL-2R 
1825 iu et al. 
Species/isotype 
Rat IgG2a 
Rat IgM 
Mouse IgG2a 
Rat IgG2b 
Rat IgG2a 
Rat IgG2b 
Rat IgG2a 
Hamster IgG 
Rat IgG2a 
Rat IgG2a 
Rat IgM 
Mouse IgG2a 
Rat IgG2a 
Rat IgG2b 
Rat IgG2b 
Hamster IgG 
Rat IgG2a 
Rat IgG2a 
Rat IgGl 
before flow cytometric analysis was performed in a FACStar® flow 
cytometer (Becton Dickinson, San Jose, CA). 5,000 events were 
acquired for each sample. 
Mixed Leukocyte Cultures, To test the immunogenicity of freshly 
isolated or cultured cells, one-way mixed leukocyte cultures (4 x 
105 cells in 200 ILl per well in 96-well, round-bottom microcul-
ture plates) were performed with ,),-irradiated (20 Gy), allogeneic 
(BI0.BR), or syngeneic (BiD) liver NPC or spleen cells as stimu-
lators. B10 spleen cells were used as responders, which were T cell 
enriched by sequential removal of plastic-adherent cells (1 h at 37°C) 
and by passage (1 h) through a nylon wool column. Cultures were 
maintained in RPMI-1640 complete medium supplemented with 
10% heat-inactivated FCS for 72 h in 5% CO2 in air; for the final 
18 h, 10 ILl PH]TdR (1 ILCi) was added to each well. Cells were 
harvested onto glass fiber disks using a multiple cell harvester and 
the degree of thymidine incorporation was determined in a liquid 
scintillation counter. Results were expressed as mean counts per 
minute ± 1 SD. 
Phagocytosis Assay, SRBC (Remel, Lenexa, KS) were washed 
extensively with ice-cold PBS and opsonized at 37°C for 15 min 
Supplier! clone name (American Type 
Culture Collection [Rockville, 
HD] No,) 
Ml/9,3.4 (TIB 122) 
RA3-3A 1/6.1 (TIB 146) 
PharMingen; 14-4-4S (HB32) 
33Dl (TIB 227) 
NLDC-145; Dr. R. M. Steinman, 
The Rockefeller University, New York 
F 4/80 (HB 198); Dr. R. M. Steinman 
PharMingen; 53-2.1 
PharMingen; 145-2Cll 
PharMingen; RM-4-5 
PharMingen; 53-6.7 
JI1D (TIB 183) 
Dr. W. H. Chambers, University of Pittsburgh 
Dr. W. H. Chambers 
PharMingen; 2.4G2 (HB 197) 
Ml170. (TIB 128) 
N418; Dr. R. M. Steinman 
PharMingen; 2D2C (TIB 235) 
Serotec; KAT-l 
PC 61 5.3 (TIB 222) 
with a 1:100 subagglutinating concentration of rabbit anti-SRBC 
IgG (Sigma Chemical Co.) . The washed SRBC were then suspended 
in RPMI-1640 and incubated at 37°C for 2 h (8:1) with freshly 
harvested suspensions of GM-CSF-stimulated, non- and loosely ad-
herent liver-derived cells before and after exposure to collagen. 
Noningested SRBC were lysed in hypotonic solution (75"10 RPM 1-
1640:25"10 H 20) for 10 s. The cells were cytocentrifuged, fixed in 
methanol, and stained with Giemsa. Phagocytic activity (the pres-
ence of ~3 ingested SRBC) was determined "blind" by light mi-
croscopic examination. Overnight cultured peritoneal macrophages 
from the same mouse strain were used as positive controls. 
Immunocytochemistry. Cytocen trifuge preparations were stained 
using avidin-biotin-peroxidase complex (ABC-P; Boehringer Mann-
heim Corp., Indianapolis, IN) staining procedures. Briefly, speci-
mens were air-dried at RT, before fixing in acetone for 5 min . The 
slides were then washed in PBS and incubated for 1 h at RT with 
biotinylated mouse IgG2a anti-mouse I-p·d.p,' mAb. After three 
washes of 5 min each in PBS, the slides were incubated with 
streptavidin-biotin-peroxidase complex for 30 min at RT and the 
color reaction was developed for 6 min using a peroxidase chro-
mogen kit (AEC; Biomedia Corp., Foster City, CAl. Cells were 
counterstained lightly with hematoxylin. Controls included the 
omission of Ab and the use of isotype-matched irrelevant mAb. 
Dendritic Cell Homing. la-depleted or nondepleted cultured 
BI0.BR liver- or spleen-derived cells were washed in RPMI-1640 
and injected subcutaneously (1 or 2.5 x lOS cells in 50 ILl) into 
one hind footpad or intravenously (1()6 in 200 ILl) via the lateral 
tail vein of normal B10 mice. 1-5 d later, the draining popliteal 
lymph node and spleen were removed and embedded in Tissue-
Tek® (O.C.T. Compound, Miles Inc., Elkhart, IN). 10-llm sections 
were cut using a cryostat microtome at -30°C and melted directly 
onto slides at RT. Slides were air-dried at RT overnight, then stored 
at - 70°C until used. Just before staining, the slides were equi-
librated at RT, then fixed in acetone before immunoperoxidase 
staining as described above. Tissue controls included sections of 
normal recipient strain (BI0) tissues. 
Results 
Isolation oj Liver·derived NPC and Their Proliferation in Re-
sponse to GM-CSF. Approximately 7-10 x 106 NPC were 
isolated per normal mouse liver, with <5'70 hepatocyte con-
tamination by microscopic examination. A large proportion 
of the total cell population derived from both the liver and 
spleen was B220+ (B cells) ("'40-50'70 in liver and 60-80'70 
in spleen) as determined by flow cytometric analysis. These 
cells accounted largely for the MHC class II + (I-E +) popu-
lation of comparatively small-sized cells derived from each 
organ. Within the overall population of NPC, Thy1.2+ T 
cells were present in smaller numbers compared with B cells 
("'20'70 for liver and 30-40'70 for spleen). It is interesting 
to note that within the population of small-sized cells, a dis-
tinct subpopulation of cells bearing the DC-restricted, inter-
digitating cell marker NLDC 145 was found in the liver, but 
not the spleen. Gating for the more granular and larger-sized 
cells also revealed a much greater population of NLDC 145 + 
b 
Figure 2. Illustration of the development and isolation of normal mouse liver-derived DC progenitors in liquid cultures supplemented with GM-CSF. 
(a) An early aggregate of proliferating putative DC progenitors (day 4) attached to strongly adherent macrophages and showing typical, loosely adherent 
cells (arrows) that were released from the aggregates. At days 2 and 4 nonadherent granulocytes were removed by gentle aspiration of the culture superna· 
tant and replacement with fresh, GM-CSF-supplemented medium. x l00. (b) Giemsa-stained cytocentrifuge preparation showing three released cells 
(day 6) which exhibit irregular-shaped, eccentric nuclei, variable degrees of vacuolation, absence of prominent cytoplasmic granules, and distinct cyto· 
plasmic processes. x 600. 
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cells among liver NPC as compared with spleen cells. In-
deed, the presence of these NLDC 145 + cells represented the 
major phenotypic difference between splenocytes and liver 
NPC using the large panel of mAbs tested (data not shown). 
After 4-d culture of liver or spleen NPC in GM-CSF, during 
which time nonadherent granulocytes were removed by gentle 
washes, growth of cell "clusters" attached to a layer of ad-
herent cells was evident (Fig. 2 a). Many dendritic-shaped 
cells appeared to have been released from the clusters and ex-
hibited sheetlike cytoplasmic processes (Fig. 2 b). With more 
prolonged culture in GM-CSF, these cells detached from the 
aggregates and many mononuclear cells with a typical den-
dritic shape were seen either loosely attached or floating in 
the culture medium. However, in the absence of GM-CSF, 
no cellular proliferation was seen. Adherent macrophages and 
fibroblasts also expanded in the liver or spleen cell cultures 
in the presence of GM-CSF, but remained firmly attached 
to the plastic surface. The floating or loosely adherent puta-
tive DC were harvested by gentle aspiration for further pheno-
typic or functional analyses. By day 7 of culture, "'2.5 x 
106 of these cells per mouse liver could be harvested from 
the cultures. 
Microscopic and Immunophenotypic Analysis oj CM-CSF-
stimulated Liver and Spleen Cells. At the microscopic level, 
the cells released from proliferating aggregates of GM-
CSF-stimulated liver or spleen cells exhibited typical mor-
Figure 3. (a and b) Transmission electron micrographs of loosely adherent cells exhibiting DC morphology released from proliferating aggregates 
of GM-CSF-stimulated liver-derived cells 9 d after initiation of the cultures. The cells exhibit irregular-shaped nuclei, prominent nucleoli, few electron-
dense granules, and numerous mitochondria . (c and d) Scanning electron micrographs of typical nonadherent cells from the same culture, exhibiting 
distinct cytoplasmic veils. Bars, 1 J.'m. 
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phological features of DC, including (in many but not all 
cells) irregular-shaped eccentric nuclei, numerous "veil"-like 
cytoplasmic dendrites, abundant mitochondria, and few elec-
tron-dense granules (Fig. 2 b and Fig. 3, a and b). Scanning 
electron microscopy provided further, definitive evidence of 
gossamer-like veils (Fig. 3, c and d). To ascertain the surface 
phenotype of cells released from proliferating aggregates, flow 
cytometric analysis was performed after 6-10 d or further 
periods of culture in GM-CSF. Staining for cells oflymphoid 
lineage, including NK cells, was absent. As shown in Fig. 
4, the floating cells in liver-derived cultures strongly expressed 
surface antigens that are known to be associated with mouse 
DC. These included CD45 (leukocyte common antigen), heat 
stable antigen, intercellular adhesion molecule 1, CD11b 
(MAC-1), and CD44 (nonpolyrneric determinant of Pgp.1 
glycoprotein). In addition, staining of weak to moderate in-
tensity was observed for the DC-restricted markers NLDC-
145 (interdigitating cells), 33D1, N418, F4/80, and FcyRII. 
The intensity of expression of these markers on GM-
CSF-stimulated spleen cells was similar, except that 33D1 
and NLDC 145 were slightly more and less intense, respec-
tively, compared with the liver-derived cells. In contrast to 
the observation ofInaba et al. (15), however, concerning the 
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Figure 4. Merged FACScan® immunophenotypic pro£Ies of the GM-
CSF-stimulated liver-derived putative DC released from cell aggregates 
in liquid culture (day 10) and examined using rat, hamster, or mouse mAbs. 
All data were obtained from the same cell preparation at the same time. 
The result is representative of four separate experiments performed using 
cells obtained from 6-10-d cultures. Details of the mAbs are given in Table 1. 
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Figure 5. Flow cytometric analysis of MHC class II (I-Ek) expression 
on (1) GM-CSF-stimulated mouse liver putative DC and (2) spleen-derived 
DC released from proliferating aggregates in 10-d cultures. The result is 
representative of six separate experiments performed using cells obtained 
from 6-10-d cultures. 
progeny of circulating DC precursors, the liver-derived, GM-
CSF-stimulated cells expressed only a low level ofMHC class 
II (I-Ek) surface antigen molecule when compared with 
GM-CSF-stimulated spleen cells propagated under the same 
conditions (Fig. 5). The intensity of I-Ek expression could 
not be increased on either the liver- or spleen-derived cells 
by increasing the concentration of GM-CSF (0.4-0.8 ng/ml) 
and/or by extending the period of culture for up to 4 wk. 
The low intensity of I-E" expression on the liver cell popu-
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Figure 6. Allostimulatory activity of -y-irradiated. GM-CSF-stimulated 
B10.BR mouse liver putative DC (A) or splenic DC (b), using naive 
B10 (I-E -) splenic T cells as responders. The nonadherent cells were har-
vested from 10-d GM-CSF-stimulated cultures and set up at various con-
centrations with 4 x lOS responder T cells. Cultures were maintained 
for 72 h; [3H)TdR was added 18 h before harvesting. The MLR stimula-
tory activity of freshly isolated allogeneic (B.I0 BR [el) and syngeneic 
(BlO [0 l) spleen cells is also shown. The results are expressed as mean 
counts per minute (c.p. m.) ± 1 SD and are representative of at least three 
separate experiments. 
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lation suggested that these proliferating cells, though pos-
sessing several surface markers indicative of developing DC, 
were still at a phenotypically immature stage of differentia-
tion. Further efforts to induce MHC class II antigen expres-
sion included the combination of GM-CSF with TNF-a (500 
VlmI) andlor IFN-y (1,000 Vlml) for up to 5 d and culture 
on a "feeder layer" of irradiated, syngeneic spleen cells. None 
of these treatments affected significantly the expression of 
cell surface I-P on the putative "immature" liver DC. 
Allostimulatory Activity by GM-CSF-propagated Liver-derived 
Cells. Fig. 6 shows that, when compared with GM-CSF-stimu-
lated spleen cells propagated and harvested using the same 
techniques, the cultured liver-derived cells failed to induce 
naive T cell proliferation. GM-CSF-stimulated, spleen-derived 
DC, however, which expressed higher levels of surface MHC 
class II antigen, were more efficient inducers of primary al-
logeneic T cell responses than were freshly isolated spleen 
cells. Furthermore, failure of the GM-CSF-stimulated puta-
tive liver DC to induce MLR contrasted with the potent al-
lostimulatory activity of an overnight-cultured, nonadherent, 
low density, mature, DC-enriched population that was pre-
pared from freshly isolated normal B10.BR mouse liver NPC, 
using conventional methods (3, 21) (data not shown). 
Induction oJMHC Class II on GM-CSF--stimulated Liver-derived 
Cells after Exposure to Type-l Collagen. We also determined 
whether the GM-CSF-propagated putative "immature" liver 
DC might undergo maturation when allowed to propagate 
in contact with extracellular matrix protein (type-1 collagen) 
that is expressed constitutively in the local microenvironment 
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Figure 7. The expression of various DC-restricted markers and ofF4/S0 
on GM-CSF-stimulated putative liver DC before (1) and after (2) the ex-
posure of the cells to type-1 collagen. 7 -d cultures of liver-derived cells 
released from aggregates in GM-CSF-supplemented medium were exposed 
for a further 3 d to type-1 collagen or maintained without collagen in 
the continuous presence of GM-CSF (0.4 ng/ml). An isotype-matched 
irrelevant Ab was used as a negative control. The results are representative 
of three separate experiments. 
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of the liver (portal triads, stroma of the portal spaces, and 
around central veins) in which mature DC are most readily 
detected (11, 13). Day 7 GM-CSF-stimulated liver cells ex-
pressing low levels of MHC class II were transferred to cul-
ture plates precoated with type-1 collagen and maintained 
for three more days in the presence of GM-CSF. Cell prolifer-
ation was observed on the collagen-coated plates, accompa-
nied by a relative increase in nonadherent cells as compared 
with control cultures (collagen free). lmmunophenotypic 
analysis of the nonadherent cells showed marked upregula-
tion in the intensity of expression of the DC markers 
NLDC145, 33D1, and N418 (Fig. 7). Such upregulation 
of DC markers has been shown previously in GM-CSF-stimu-
lated mouse bone marrow cultures (16). Of particular interest, 
however, was the marked upregulation of MHC class II 
expression observed on liver DC propagated for an additional 
3 d on collagen-coated plates as compared with similar cells 
maintained in collagen-free cultures. This observation was 
confirmed by immunocytochemical staining of cytospins of 
these cells (Fig. 8, a and b). To address the possibility of en-
richment of class 11+ cells, vs upregulation of class II in col-
lagen and GM-CSF cultures, an attempt was made to deplete 
all of the Ia + population by complement-mediated lysis be-
fore exposure to collagen. Similar to the 7-d GM-CSF 
propagated DC, the Ia - population obtained from these 
cells also markedly upregulated its MHC class II expression 
when exposed to collagen for 3 d in the continued presence 
of GM-CSF (Fig. 8, c and d and Fig. 9). Additionally, cell 
proliferation was also observed as ~2.5 x 106 and 1.5 x 
106 nonadherent cells, respectively, per well, were recovered 
3 d after seeding 106 la - cells into collagen-coated or 
collagen-free wells. The number of adherent cells was inversely 
related to the number of nonadherent cells recovered from 
the wells. Furthermore, the intensity of this MHC class II 
expression was similar to or greater than that observed on 
GM-CSF-stimulated spleen-derived DC (day 10) which also 
expressed high levels of la with or without exposure to the 
extracellular matrix protein (Fig. 8 e). To control for pos-
sible trace contamination of the collagen with endotoxin and 
to rule out possible endotoxin-mediated upregulation of class 
II on the developing liver DC, 7-d cultures were exposed 
to LPS (50 Itg/ml) for a further 3-d period in the presence 
of GM-CSF. No increase in class II expression was observed. 
Reduction in Phagocytic Activity after Exposure of Developing 
Liver LC to Type-1 Collagen. We compared the ability of 
the developing, liver-derived DC to phagocytose opsonized 
SRBC before and after 3-d exposure of the cells to type-1 
collagen in the continued presence of GM-CSF. In two sepa-
rate experiments, after exposure to collagen, and with 
concurrent upregulation of MHC class II expression, the liver-
derived DC showed a marked reduction in erythrophago-
cytic activity (Fig. 10). 
Development of MLR Stimulatory Activity after Exposure of 
Developing Liver DC to Type-l Collagen. After exposure to 
collagen, la-depleted liver DC became potent inducers of 
MLR, in marked contrast to la-depleted cells maintained in 
GM-CSF alone, which failed to elicit T cell proliferation (Fig. 
a b c 
Figure 8. Immunoperoxidase staining of cytocentrifuge preparations of GM-CSF-stimulated liver- or spleen-derived cells for MHC class II (I-Ek) 
antigen. (a) A very low level of MHC class II expression was found on liver-derived putative DC released from aggregates after 7 d in culture. (b) 
After an additional 3-d exposure to type-1 collagen in the continued presence of GM-CSF, I-Ek expression on liver cells was greatly increased. (c) Few 
class IIdim cells from (a) were depleted by anti-Ia mAb and complement. (d) After 3-d exposure to collagen type-1 in the continued presence of GM-
CSF, the expression of class J[ was markedly upregulated. (e) GM-CSF-stimulated spleen-derived DC, which were propagated and harvested (day 10) 
under similar conditions in the absence of collagen and which showed a high level of MHC class II expression. x 600. 
11). These class Ilbright liver-derived DC also proved much 
stronger MLR stimulators than freshly isolated spleen cells, 
although not as potent as GM-CSF-stimulated splenocytes. 
Homing ofLiller-derilled DC. To assess the homing ability 
of the developing liver DC propagated in culture, lO-d GM-
CSF-stimulated cells (lor 2.5 x lOS low I-Ek expression 
or la - after complement-mediated lysis, respectively) were 
injected subcutaneously into one hind footpad or intravenously 
into allogeneic B10 (I-E -) recipients. For comparative anal-
ysis, strongly class 11+ GM-CSF-stimulated spleen DC (10-d 
cultures) were injected into separate animals. 1-5 d later, the 
animals were killed and cryostat sections of the draining lymph 
nodes (where appropriate) and spleens were stained with 
donor-specific mAb to 1-Ek. As shown in Fig. 12, liver-
derived cells propagated in GM-CSF-supplemented cultures 
homed after injection almost exclusively to the T cell areas 
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Figure 9. Flow cytometric 
analysis of the expression of MHC 
class II (I-Ek) on GM-CSF-stim-
ulated putative liver DC with or 
without subsequent exposure to 
type-l collagen. Ia + cells were 
depleted from 7 -d cultures of liver-
derived cells released from ag-
gregates in GM-CSF-supplement-
ed medium by treatment with 
anti-Ia (I-Ek) mAb and comple-
ment. The cells were then exposed 
for a further 3 d to type-l collagen (1) or maintained without collagen 
(2) in the continuous presence of GM-CSF (0.4 ng/ml). An isotype-matched 
irrelevant Ab was used as a negative control. The results are representative 
of three separate experiments. 
b 
Figure 10. Exhibition of phagocytic activity by GM-CSF-stimulated, 
liver-derived DC before and after culture in the presence of type-l col-
lagen. (a) Cells released from aggregates 7 d after the initiation of liver 
cell cultures showed avid phagocytic activity after exposure for 2 h at 37°C 
to SRBC opsonized with a subagglutinating concentration of rabbit IgG 
antibody. In contrast (b), liver-derived DC cultured for a further 3 d 00 
collagen-coated plates in the continued presence of GM-CSF showed 
markedly reduced phagocytic activity. Giemsa x 400. 
1830 Maturation of Liver-derived Dendritic Cells 
/ 
140 
120 
100 
80 
60 
40 
20 
- - - - - -j- - - - - - - - - -I 
o+-------~----~~~r---~--~~~~~" 
10 ' 10 4 10 5 
Stimulator Cell Number 
Figure 11. Allostimulatory activity of 'Y-irradiated, GM-CSF-stimu-
lated BI0.BR liver-derived DC from which all class II + cells were depleted 
(after 7-d culture) with anti-I a mAb and complement; the cells were then 
of recipients' spleens in close proximity to arterioles. Similar 
observations were also made in the draining lymph node of 
footpad-injected mice (data not shown). Moderate to intense 
I-Ek expression was detected on the liver-derived cells, many 
of which also exhibited distinct dendritic morphology. At 
day 5 after injection, liver-derived DC in the recipient's spleen 
were more abundant than strong class 11+ spleen-derived 
DC, which also homed after injection to T cell areas of 
recipients' spleens and lymph nodes (data not shown). Similar 
observations were made whether ladim or la-depleted cells 
were injected. In the latter instance, however, the incidence 
exposed to type 1-collagen for 3 d. (.) la-depleted stimulator cells main-
tained for 3 d with GM-CSF in collagen-free wells; (0) similarly derived 
and treated cells, except for exposure for 3 d to type-1 collagen with con-
tinued presence of GM-CSF. There was no increase in the MLR stimula-
tory activity of untreated or la-depleted liver-derived cells maintained in 
GM-CSF alone for extended periods beyond 7 d (up to 35 d; data not 
shown). The allostimulatory activity of freshly isolated (.6) and GM-
CSF- stimulated (day 10) B10.BR spleen-derived DC (e) and (X) syn-
geneic (BI0) spleen cells is also shown. The results are expressed as mean 
counts per minute ± 1 SD. 
Figure 12. Homing ability of GM-CSF-stimulated B10.BR liver-derived cells (I-Ed;m) released in culture from proliferating cell aggregates. The 
cells (lor 2.5 x 105) were injected subcutaneously into one hind footpad of B10 (I-E -) recipients and detected by immunohistochemistry in cryostat 
sections of draining lymph nodes and spleen 1-5 d later. The spleen sections were stained using the ABC peroxidase procedure with donor-specific 
mouse anti-I-Ek mAb or appropriate controls. Strongly MHC class II-positive cells were readily identified in the T-dependent areas often in close prox-
imity to arterioles. x 400. Similar results were obtained when animals were injected with cells that were depleted of all of the class II + population 
with anti-Ia mAb and complement, although the numbers of I-P+ cells detected in the recipients' tissues were significantly reduced . (Inse/) Dendritic 
morphology is evident in a high-power view of a donor I-P+ liver-derived cell in the recipient's spleen . x 1,000. 
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of positive cells was reduced. These observations suggest that 
the immature liver-derived DC after injection upregulate their 
MHC class II surface antigen in vivo. 
Discussion 
It has been shown previously in mice that orthotopic 
B10.BR (I-Ek) hepatic allografts survive permanently when 
transplanted into nonimmunosuppressed B10 (I-E -) recipi-
ents (MHC class I and II disparate) and induce donor-specific 
acceptance of skin and cardiac grafts (10). In the present studies, 
cultured liver NPC and splenocytes from B10.BR mice were 
examined. The myeloid lineage cells propagated selectively 
from the spleen in the presence of GM-CSF had the mor-
phologic features, cell surface immunophenotype, allostimula-
tory activity, phagocytic capacity, and homing characteris-
tics classically ascribed to DC (5). 
Unlike DC cultured from the spleen, however, the majority 
of GM-CSF-stimulated NPC derived from the liver had weak 
or no surface expression of MHC class II and failed to stimu-
late naive B10 T-Iymphocytes in MLR. Consequently, their 
identity as DC could not be established unequivocally. This 
dilemma was resolved by culturing the liver cells in the pres-
ence of type-1 collagen, a strategy employed to mimic the 
microenvironment of the intact liver, where mature DC are 
found in areas that are rich in type-1 collagen, i.e., portal 
tracts, around central veins, and in Glisson's capsule (17). After 
3 d of exposure to type-1 collagen in the presence of GM-
CSF, the putative hepatic DC markedly upregulated the ex-
pression ofMHC class II with concomitant reduction in their 
phagocytic capacity and acquisition of potent allostimulatory 
activity. These observations could reflect selective "enrich-
ment" after exposure to collagen of few Iadim cells, rather 
than the functional and phenotypic maturation of liver DC 
precursors. This argument however, was dismissed after our 
findings that Ia - GM-CSF-propagated liver DC, when ex-
posed to collagen, also matured into potent APCs expressing 
equally high levels of MHC class II. 
Evidence that the foregoing lineage of hepatic NPC can 
exhibit the homing capacity characteristic of DC was ob-
tained by injecting class IIdim or class II - cells subcutaneously 
into the footpad or intravenously into normal B10 mice. When 
the recipients were killed after 1-5 d, the injected cells had 
homed to the draining lymph node and spleen, where they 
were easily identified as donor in T cell areas by their moderate 
to dense MHC class II (I-Ek) expression. 
These findings are consistent with the key role we have 
ascribed to the DC in the migration of bone marrow-de-
rived cells from whole organs after their transplantation, 
resulting in low level chimerism and donor-specific immuno-
logic nonreactivity (1, 2, 10). We have postulated recently 
that cell migration and chimerism may be the basis for the 
acceptance of all allografts (1, 2, 7). The unusual toleroge-
nicity of the liver could mirror a comparatively heavy con-
tent within this organ of immature or progenitor DC (22), 
that was shown in this study to rapidly disseminate and up-
regulate their expression of MHC class II in allogeneic 
recipients. Furthermore, work in our laboratory has shown 
that using GM-CSF, the propagation of myeloid lineage cells 
from normal mouse heart NPC is much more difficult to 
achieve. It has been suggested from observations in rats (6) 
and humans (7), and demonstrated unequivocally in mouse 
liver transplant experiments (10), that multiple hematolym-
phopoietic lineages participate in the leukocyte traffic that 
occurs after organ transplantation. These lineages may sur-
vive permanently without treatment in mice (10) or after an 
induction course of immunosuppression in rats (6) and even 
in some humans (7). The probability that there are pluripo-
tent stem cells and immature DC (among other lineages) in 
the bone marrow-derived interstitial population of nonlym-
phoid organs is inherent in our cell migration and chimerism 
hypothesis (1, 2). 
The survival and maturation of liver DC progenitors that 
home to T cell-dependent areas of lymphoid tissue in the 
allogeneic recipients herein reported is consistent with the 
contention of Demetris et al. (6) and Qian et al. (10) that 
the destination of the cell, trafficking after whole organ trans-
plantation, is lineage specific, following the same routes taken 
by syngeneic cells of the same lineages. After liver and other 
organ transplantation, immature cells of DC lineage may un-
dergo in vivo maturation with endogenous GM-CSF and other 
cytokines in an in vivo recapitulation of the cell culture ex-
periments of Romani et a1. (23), and Inaba et al. (15, 16), 
and of the in vitro experiments reported herein. The extent 
and tempo of this maturation process are undoubtedly 
influenced by the level of host immunosuppression when such 
treatment is used. However, all of our in vivo experiments 
were performed in the absence of therapy or host precondi-
tioning. 
There are several lines of evidence that complex interac-
tions between donor leukocytes and the recipient's immune 
system can lead to decreased host alloresponsiveness and even 
to tolerance induction (1, 2, 6, 7, 24-27). There are also 
numerous reports that mature T cells can be tolerized to al-
logeneic antigens outside the thymus (28, 29). It is therefore 
plausible that chimeric cells present in the periphery may play 
a key role in achieving allotolerance. The tolerogenic impli-
cations of the rapid egress from transplanted whole organs 
(the liver above all) of postulated precursor or progenitor DC 
exhibiting low MHC class II expression and low T cell-stimu-
lating activity are considerable. The existence of subpopula-
tions of murine DC with a veto function has recently been 
proposed (30). Moreover, HLA-DR dim allogeneic donor 
bone marrow cells, shown to exhibit veto cell activity (inac-
tivation of T helper cells or cytotoxic T cell precursors) have 
been postulated to be immature DC (31). Such immature 
DC, which were shown in our experiments to have avid 
phagocytic activity in culture, might be expected to elicit 
a "deviant" (tolerogenic) local and systemic immune response 
shortly after their injection. The precise basis of the DC-T 
cell interaction leading to tolerance induction is uncertain, 
but would clearly depend on the relative affinity or avidity 
(compared with effective APC) of the donor DC-TCR in-
teractions and on the expression on the former cells, of adhesins 
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and costimulatory molecules, such a B7/BB1. These aspects 
of the developing liver-derived DC are under further investi-
gation in our laboratory. 
A well-studied example of an atypical or deviant cytokine-
modulated immune response induced by bone marrow-de-
rived APC has been provided by Wilbanks and Streilein (32). 
They have studied class IIdim APC with dendritic mor-
phology which are now thought to be variant DC in the 
iris, ciliary body, and other tissues lining the anterior chamber 
of the eye (33, 34). When BSA was injected into the anterior 
chamber and taken up by these APC, it was presented ineffec-
tively both to the T cells locally, and within a few hours, 
in the spleen, after the arrival there of the APC-peptide com-
plexes. The consequence was a dampened systemic as well 
as local (ocular) immune response to a subsequent challenge 
with the antigen. 
The exploitation of putative tolerogenic DC for the in-
duction of controlled transplantation tolerance as a conse-
quence of donor cell chimerism is not hard to imagine. Al-
though DC precursors apparently are concentrated in the liver, 
a similar subpopulation presumably may exist in all other 
tissues and whole organs and particularly in the bone marrow, 
which is the origin of the leukocyte population of the liver 
and elsewhere. The clinical implications of these observations 
are far-ranging, prompting us to initiate a more thorough 
investigation of DC precursors in bone marrow, spleen, and 
other tissues. 
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